UC Davis and Lawrence Livermore National Laboratory seek industry partners to develop new bio and medical technology products

October 17, 2000

(Sacramento, Calif., Livermore, Calif., October 18, 2000) -- The University of California, Davis, Health System and Lawrence Livermore National Laboratory today formed the Industry Partners Consortium for Bio and Medical Technology Development. The group provides private-sector companies with access to medical and technological expertise to assist them in developing innovative medical products.

Private-sector companies interested in joining the IPC are invited to attend the first Bio and Medical Technology Summit on Nov. 7-8 at the University of California Laurel Heights Conference Facility in San Francisco. The summit, hosted by UC Davis and Lawrence Livermore, will feature seminars on optical cancer diagnostics, molecular oncology and other advances in the detection and treatment of cancer, Bio-MEMS (micro electro mechanical systems), chromosome region-specific expressed gene in solution and applications in telemedicine.

The IPC is a joint effort between UC Davis and Lawrence Livermore to form partnerships with industry. The goal of the consortium is to improve patient outcomes by developing new medical technologies that apply the medical expertise of doctors at UC Davis Health System and the technical expertise of scientists at Livermore Lab. Through collaborations with industry partners, the IPC will accelerate the development of these new bio and medical technologies so that they are commercially available to physicians and patients.

By bringing together leading scientific and medical experts with industry, the consortium will help translate research discoveries into practical applications that improve human health and well being.
-end-
To register for the Bio and Medical Technology Summit, call John Tupin, UC Davis, at 916-734-4699 or e-mail john.tupin@ucdmc.ucdavis.edu. For more information about the IPC, call John Marion, Lawrence Livermore National Laboratory, at 925-423-6788 or e-mail marion1@llnl.gov.

UC Davis Health System is a fully integrated academic health system encompassing the UC Davis School of Medicine and its 528-bed, acute-care hospital and affiliated outpatient centers, including a network of physician practices in 15 northern California communities. It has distinguished itself as a leader in functional genomics, telehealth, trauma and emergency medicine, and primary care.

Founded in 1952, Lawrence Livermore National Laboratory is a national security laboratory with a mission to ensure national security and apply science and technology to the important issues of our time. Lawrence Livermore National Laboratory is managed by the University of California for the U.S. Department of Energy.

CONTACT:
David Ong
UC Davis Health System
916-734-9049
daong@ucdavis.edu

Anne M. Peterson
Lawrence Livermore National Laboratory
925-422-9799
peterson60@llnl.gov


University of California - Davis Health System

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.